Stress cardiomyopathy: Difference between revisions

Jump to navigation Jump to search
Aditya Govindavarjhulla (talk | contribs)
 
(9 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Infobox_Disease
{{Infobox_Disease
  | Name          = {{PAGENAME}}
  | Name          = {{PAGENAME}}
Line 16: Line 15:
}}
}}
{{Stress cardiomyopathy}}
{{Stress cardiomyopathy}}
{{CMG}}
{{CMG}}; {{AE}}{{DN}} {{AKK}}


{{SK}} Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction
{{SK}} Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; LVABS; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction; stress-induced cardiomyopathy; SIC
== [[Stress cardiomyopathy overview|Overview]] ==
== [[Stress cardiomyopathy overview|Overview]] ==
==[[ Stress cardiomyopathy historical perspective| Historical Perspective]]==
==[[ Stress cardiomyopathy historical perspective| Historical Perspective]]==
Line 32: Line 31:
== [[Stress cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]] ==
== [[Stress cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]] ==
==[[Stress cardiomyopathy risk factors | Risk Factors]]==
==[[Stress cardiomyopathy risk factors | Risk Factors]]==
== [[Stress cardiomyopathy screening|Screening]] ==


== [[Stress cardiomyopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==
== [[Stress cardiomyopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==
Line 43: Line 40:
== Treatment ==
== Treatment ==


[[Stress cardiomyopathy medical therapy|Medical Therapy]] | [[Stress cardiomyopathy surgery|Surgery]] | [[Stress cardiomyopathy primary prevention|Primary Prevention]] | [[Stress cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Stress cardiomyopathy future or investigational therapies|Future or Investigational Therapies]]
[[Stress cardiomyopathy medical therapy|Medical Therapy]] | [[Stress cardiomyopathy surgery|Surgery]] | [[Stress cardiomyopathy primary prevention|Primary Prevention]] | [[Stress cardiomyopathy secondary prevention|Secondary Prevention]] | [[Stress cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Stress cardiomyopathy future or investigational therapies|Future or Investigational Therapies]]


== Case Studies ==
== Case Studies ==
Line 49: Line 46:
: [[Stress cardiomyopathy case study one|Case #1]]
: [[Stress cardiomyopathy case study one|Case #1]]


[[de:Stress-Kardiomyopathie]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 16:29, 14 July 2020

Stress cardiomyopathy
Schematic representation of Takotsubo cardiomyopathy (A) compared to the situation in a normal person (B).
ICD-9 429.83
DiseasesDB 33976
MeSH 054549

Stress cardiomyopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy

Future or Investigational Therapies

Case Studies

Case #1

Stress cardiomyopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stress cardiomyopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stress cardiomyopathy

CDC on Stress cardiomyopathy

Stress cardiomyopathy in the news

Blogs on Stress cardiomyopathy

Directions to Hospitals Treating Stress cardiomyopathy

Risk calculators and risk factors for Stress cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2] Arzu Kalayci, M.D. [3]

Synonyms and keywords: Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; LVABS; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction; stress-induced cardiomyopathy; SIC

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:WikiDoc Sources